Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Article in English | IMSEAR | ID: sea-157645

ABSTRACT

Vaginitis is among the most common conditions for which women seek medical care, with vaginal discharge accounting for approximately 10 million office visits each year. Since there are no published studies till date that evaluated the Clinical Effectiveness and Safety of Topical Cream of Formula A [Ofloxacin (0.75 % w/w) + Ornidazole (2% w/w) + Terbinafine Hydrochloride (1% w/w) + Clobetasol Propionate (0.05% w/w)] compared to Formula B [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], Formula C [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], and Formula D [Clotrimazole (1%w/w) + Beclometasone Dipropionate (0.025%w/w) + Neomycin Sulphate (0.5% w/w)], in mild to moderate vaginitis, hence we undertook this randomized controlled Post Marketing Multicentric trial. Materials and methods: Female subjects diagnosed with mild to moderate symptoms of Vaginitis were eligible and those fulfilling the subject selection criteria were randomized to receive either Formula A, Formula B, Formula C or Formula D for 14 days. The Primary efficacy measures were assessment of symptoms of Vaginitis i.e. vaginal pruritis, vaginal irritation, vaginal soreness or pain, dyspareunia, vaginal erosion and vaginal inflammation and Secondary efficacy measures were assessment of Physical characteristics of vaginal discharge, assessment of pH of vaginal discharge and Microbiological evaluation. Assessment of Safety was done by recording the occurrence of adverse drug reactions. Results: The clinical success rates were comparable and even far better in case of Formula A group (in vaginal pain, Dyspareunia and vaginal erosion it was 100 %, in case of vaginal inflammation it was 92.655 % while in case of vaginal irritation, it was 94.767 % and vaginal pruritus, it was 87.096 %). Adverse events were mild and self limiting while it was totally absent in case of Formula A group. Conclusion: Topical Cream of Formula A is safe and effective for the treatment of mild to moderate vaginitis.


Subject(s)
Adult , Beclomethasone/administration & dosage , Beclomethasone/analogs & derivatives , Clobetasol/administration & dosage , Clotrimazole/administration & dosage , Drug Combinations , Dyspareunia/drug therapy , Dyspareunia/microbiology , Female , Humans , Naphthalenes/administration & dosage , Naphthalenes/analogs & derivatives , Neomycin/analogs & derivatives , Neomycin/administration & dosage , Ofloxacin/administration & dosage , Ornidazole/administration & dosage , Vaginal Diseases/drug therapy , Vaginal Diseases/microbiology , Vaginitis/drug therapy , Vaginitis/microbiology
2.
Braz. j. morphol. sci ; 30(3): 206-208, 2013. ilus
Article in English | LILACS | ID: lil-699348

ABSTRACT

Diseases related to the urogenital system in both males and females, are common in clinical routine of smallanimal and represents important causes of morbidity and mortality in dogs and cats. Pyocolpos is a cysticdilatation of the vagina due to the accumulation of pus resulting from the genital tract obstruction. The maincause of obstruction is imperforate hymen, transverse vaginal membrane, or vaginal atresia.We present a caseof a three-year-old female Pinscher with a history of constipation for four days, even after administration oflaxatives and enema, and estrus for ten days without a report of cover. Physical examinations were performed,which revealed increased abdominal size. Ultrasound confirmed the presence of large amounts of vaginal fluid.Exploratory laparotomy was performed, which confirmed the diagnosis of pyocolpos. Although pyocolposis a rare congenital malformation in female domestic animals, this report of its existence underscores theimportance of more accurate clinical research when increased abdominal size is noted by veterinarians.


Subject(s)
Animals , Female , Dogs , Abdomen , Congenital Abnormalities/diagnosis , Vaginal Diseases/microbiology , Urogenital Abnormalities , Vagina/abnormalities , Laparotomy , Ultrasonography
4.
Rev. chil. obstet. ginecol ; 77(5): 338-341, 2012. tab
Article in Spanish | LILACS | ID: lil-657724

ABSTRACT

Objetivo: Determinar las infecciones genitourinarias como factores de riesgo para parto pretérmino en adolescentes. Método: Estudio de casos y controles en las Unidades de Medicina Familiar del IMSS Querétaro, periodo octubre 2010 a octubre 2011. Se incluyeron 35 adolescentes con parto pretérmino y 148 con parto a término, mediante muestreo no aleatorio por cuota; se excluyeron aquellas con preeclampsia, eclampsia u otras enfermedades. Los datos se recolectaron del expediente clínico electrónico. Se estudiaron variables sociodemográficas; antecedentes gineco-obstétricos; tipo de parto (pretérmino y término); e infecciones urinarias y vaginales. La infección de vías urinarias fue diagnosticada mediante urocultivo y/o examen general de orina, con >105 UFC y >10 leucocitos por campo, respectivamente. La infección vaginal se diagnosticó por exudado vaginal con reporte de patógenos y/o por clínica. El análisis se realizó con porcentajes, promedios, chi2, razón de momios (Odds Ratio), prueba de t e intervalo de confianza. Resultados: De las adolescentes con parto pretérmino el 54,3 por ciento presentaron infección de vías urinarias, mientras que solo 33,8 por ciento de estas presentaron parto a término (p=0,02). El 57,1 por ciento de las adolescentes con parto pretérmino presentaron infección vaginal en comparación con 35,1 por ciento de las de parto a término (p=0,01). Conclusión: Las infecciones vaginales y urinarias incrementan dos veces el riesgo de presentar parto pretérmino en adolescentes.


Objective: To determine genitourinary infections as risk factors for preterm delivery in teenagers. Method: Case-control study in the Family Medicine Unit IMSS Querétaro, from October 2010 to October 2011. We included 35 teenagers with preterm delivery and 148 who delivered at term, using non-random sampling, we excluded those with preeclampsia, eclampsia or other diseases. Data were collected from electronic medical record. We studied socio-demographic variables, gyneco-obstetrics antecedents, mode of delivery (preterm and term), and genitourinary infections. Urinary tract infection was diagnosed by urine culture or urinalysis, with > 105 CFU and >10 leukocytes per field, respectively. Vaginal infection was diagnosed by vaginal culture with report of pathogens and / or by clinic. The analysis was performed using percentages, averages, chi-squared test, odds ratio, t-test and confidence intervals. Results: The 54.3 percentof the teenagers with preterm delivery had urinary tract infection, while only 33.8 percent of those with term delivery presented it (p = 0.02). Also 57.1 percent of adolescents with vaginal infection had preterm delivery compared with 35.1 percent of those giving birth at term (p=0.01). Conclusion: Vaginal and urinary infections increase twice the risk of preterm delivery in teenagers.


Subject(s)
Humans , Female , Pregnancy , Adolescent , Vaginal Diseases/epidemiology , Vaginal Diseases/microbiology , Urinary Tract Infections/epidemiology , Obstetric Labor, Premature/epidemiology , Pregnancy Complications, Infectious , Vaginal Diseases/complications , Vaginal Diseases/virology , Educational Status , Case-Control Studies , Risk Factors , Urinary Tract Infections/complications , Mexico , Obstetric Labor, Premature/etiology
5.
Rev. chil. obstet. ginecol ; 74(2): 77-82, 2009. ilus
Article in Spanish | LILACS | ID: lil-627369

ABSTRACT

OBJETIVO: Determinar la prevalencia y los factores determinantes de las infecciones vaginales en mujeres recluidas en una cárcel de Bucaramanga, Colombia. MÉTODO: Estudio de corte transversal. Se recolectaron factores sociodemográficos y clínicos, antecedentes de tabaquismo, síntomas previos y comportamiento sexual. Se tomaron muestras de flujo vaginal para determinar microscópicamente el agente causante de infección. Se utilizó regresión log-binomial para calcular razones de prevalencia (RP), intervalos de confianza (IC95%) y valores p. El ajuste global del modelo final se evaluó con la razón de probabilidad (likelihood ratio). RESULTADOS: La prevalencia global de las infecciones evaluadas fue del 28,2%. Los factores asociados con una mayor probabilidad de tener una infección vaginal al momento del estudio fueron: tabaquismo (RP: 1,71; IC95%: 1,08-2,71); edad mayor a 35 años (RP: 1,41; IC95%: 1,01-1,97); el antecedente de flujo vaginal maloliente (RP: 2,22; IC95%: 1,42-3,47) y duchas vaginales (RP: 1,71; IC95%: 1,08-2,71). CONCLUSIONES: Las mujeres que se encuentran en centros de reclusión podrían tener una mayor frecuencia de factores de riesgo para infecciones vaginales y de enfermedades sexualmente transmitidas. En este grupo es recomendable la realización de un programa de educación y de detección temprana de estas entidades como actividad regular de prevención.


OBJECTIVE.lo determine the prevalence and the determining factors of vaginal infections in women imprisoned in a prison in Bucaramanga, Colombia. METHOD: Cross-sectional study. Socio-demographic and clinical factors were collected, as well as smoking antecedents, previous symptoms and sexual behaviour. Specimens of discharge vaginal were collected by trained personal to microscopically determine the infection agent. Log-binomial regression was used to calculate prevalence ratios (PR), 95% confidence intervals (CI95%), and p-values. The likelihood ratio test was used to assess the overall significance of the model. RESULTS.lhe global prevalence of vaginal infections was 28.2%. The factors associated with a higher risk of vaginal infection at the time of the study were: a. smoking (PR: 1.71; 95%CI: 1.08-2.71); b. age over 35 (PR: 1.41; 95%CI: 1.01-1.97); c. the antecedent symptom of bad-smelling vaginal discharge (PR: 2.22; 95%CI: 1.42-3.47) and d. vaginal douches (PR: 1.71; 95%CI: 1.08-2.71). CONCLUSION:Those women imprisoned in penitentiaries may have a higher frequency of risk factors of vaginal infections. In this group, it is recommendable to create an awareness and early-detection program for these entities as a regular prevention activity.


Subject(s)
Humans , Female , Adult , Middle Aged , Young Adult , Prisons , Vaginitis/epidemiology , Infections/epidemiology , Sexual Behavior , Socioeconomic Factors , Tobacco Use Disorder/epidemiology , Vaginal Diseases/microbiology , Vaginal Diseases/epidemiology , Prevalence , Cross-Sectional Studies , Risk Factors , Analysis of Variance , Colombia
6.
Rev. chil. obstet. ginecol ; 72(4): 222-228, 2007. tab
Article in Spanish | LILACS | ID: lil-477384

ABSTRACT

Objetivo: Determinar la presencia de Escheríchia coli en fluidos vaginales de mujeres con infección vaginal y analizar la susceptibilidad antimicrobiana. Método: Se estudiaron 425 muestras de mujeres con diagnóstico clínico de infección vaginal (casos) y 100 mujeres sanas (controles). Las muestras vaginales fueron estudiadas mediante los criterios de Amsel y Nugent. Se utilizaron diferentes metodologías para identificar: Trichomonas vaginalis, Candida albicans, Gardnerella vaginalis, Chlamydia trachomatis, Myco-plasma hominis, Urea plasma urealyticum, Neisseria gonorrhoeae, Mobiluncus sp., Streptococcus agalactiae, Enterococcus faecalis, enterobacterias, bacilos Gram negativo anaerobios estrictos, Lactobacillus sp. y Staphylococcus coagulasa negativo. Resultados: Se observaron 160 casos de vaginitis y 265 de vaginosis. En los primeros predominó C. albicans y T. vaginalis, aislándose 27 cepas de E. coli en los casos de vaginosis, G. vaginalis y E.E. coli fueron los más comunes. La mayor asociación se observó entre G. vaginalis y E. coli . En 47 casos se aisló únicamente E. coli , y en los controles se observaron 6 cepas de E. coli . El estudio caso-control demostró un OR: 4,7 (95 por ciento IC: 1,91-12,27). Sobre el 90 por ciento de las cepas aisladas de E. coli demostró sensibilidad a cefotaxima, ciprofloxacino y amikacina. Conclusión: E. coli de aislados monomicrobianos podría tener un rol potencial en la patogenia de la infección vaginal.


Objective: To determine the presence of Escheríchia E. coli vaginal fluids of women with vaginal infection and to study its antimicrobial susceptibility. Methods: 425 samples of women with clinical diagnosis of vaginal infection (cases) and 100 healthy women were studied (controls). The vaginal samples were studied by means of the criteria of Amsel and Nugent. Different methodologies were used to identify: Trichomonas vaginalis, Candida albicans, Gardnerella vaginalis, Chlamydia trachomatis, Mycoplasma hominis, Ureaplas-ma urealyticum, Neisseria gonorrhoeae, Mobiluncus sp., Streptococcus agalactiae, Enterococcus faecalis, enterobacterias, strict anaerobic Gram negative bacilli, Lactobacillus sp. and coagulase negative Staphylococcus. Results: 160 cases of vaginitis and 265 of vaginosis were observed. In vaginitis predominated C. albicans and T vaginalis, and were isolated 27 E.E. coli strains. In the bacterial vaginosis, G. vaginalis and E. coli were the most common. The greater association was observed between G. vaginalis and E. coli . In 47 cases singleE. coli was isolated. In the controls 6E. coli strains were observed. The study of case-control demonstrated a OR: 4.7 (95 percent Cl: 1.91-12.27). Isolated E. coli demonstrated sensitivity over 90 percent to cefotaxime, ciprofloxacin and amikacin. Conclusion: SingleE. coli isolated could have a potential role in the pathogenia of the vaginal infection.


Subject(s)
Humans , Female , Adolescent , Adult , Vaginal Diseases/microbiology , Escherichia coli/isolation & purification , Escherichia coli , Anti-Bacterial Agents/pharmacology , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Case-Control Studies , Drug Resistance, Bacterial , Microbial Sensitivity Tests , Vagina/microbiology
8.
Ginecol. obstet. Méx ; 70(4): 203-209, abr. 2002.
Article in Spanish | LILACS | ID: lil-331098

ABSTRACT

OBJECTIVE: To identify the possible association between cervicovaginal infections (CVI) and preterm delivery. DESIGN: Cohorts. REFERENCE FRAME: Instituto Nacional de PerinatologÝa, Hospital Central Militar and Hospital General Regional No. 1, IMSS, Culiacßn, Sinaloa, MÚxico. PATIENTS: Four hundred and sixty eight patients attending prenatal control and delivery care. INTERVENTIONS: Fresh smears, Gram stain, and cervicovaginal sample culture from samples obtained during the following gestational stages: First sample at 16-24 weeks, second sample at 25-32 weeks, and third sample at 33-42 weeks. The following microorganisms were studied: Candida albicans, Gardnerella vaginalis, Ureaplasma urealyticum, Streptococcus agalactiae, Mycoplasma hominis, Neisseria gonorrhoeae, Listeria monocytogenes, and Chlamydia trachomatis. In case of a positive culture, the specific treatment was indicated. MEASUREMENTS: Positive or negative culture for each of the studied pathogens, and the presence or absence of a preterm delivery for each of the patients included in the study. RESULTS: Three hundred and ninety eight were still present at the end of the study, of which 156 had a CVI and 242 had no CVI. No differences between both groups were observed concerning preterm delivery. Significant relative risks were: In the first stage, Ureaplasma urealyticum and Mycoplasma hominis with RR = 9.0 (6.81, 11.8); in the second stage, Ureaplasma urealyticum with RR = 6.2 (3.30, 11.7) and Escherichia coli with RR = 3.4 (1.33, 8.6); in the third stage, Ureaplasma urealyticum with RR = 9.19 (6.93, 12.1). The logistic regression analysis identified Ureaplasma urealyticum during the second stage with OR = 16.6 (2.9, 93.7), statistically significant with p = 0.001. The survival analysis showed differences between the two groups concerning pregnancy duration (p < 0.001). CONCLUSIONS: There is a difference in the duration in pregnancy in patients with CVI and without CVI. Ureaplasma urealyticum is consistently associated with preterm delivery.


Subject(s)
Adult , Female , Humans , Pregnancy , Uterine Cervical Diseases/microbiology , Vaginal Diseases/microbiology , Obstetric Labor, Premature , Uterine Cervical Diseases/complications , Vaginal Diseases/complications , Pregnancy Trimester, Second , Pregnancy Trimester, Third , Risk Factors
10.
Rev. ginecol. obstet ; 12(3): 112-116, jul.-set. 2001. tab
Article in Portuguese | LILACS | ID: lil-324821

ABSTRACT

O objetivo deste trabalho foi estudar a prevalencia de fungos, Gardnerella vaginalis e Trichomonas vaginalis na secrecao vaginal de gestantes assintomaticas, no segundo e terceiro trimestre de gravidez. Excluiram-se as gestantes com...


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Candidiasis, Vulvovaginal/microbiology , Vaginal Diseases/microbiology , Gardnerella vaginalis , Vaginal Diseases/epidemiology , Gestational Age , Risk Factors , Socioeconomic Factors , Trichomonas vaginalis , Uterine Cervicitis , Vulvovaginitis
12.
Bol. micol ; 9(1/2): 15-7, jul.-dic. 1994. tab
Article in Spanish | LILACS | ID: lil-153178

ABSTRACT

En 348 análisis micológicos de secreción vaginal realizados en el CEREMIC de la Facultad de Ciencias Bioquímicas y Farmacéuticas de la UNR, se determinó un 15 porciento de resultados positivos para diferentes especies del género candida (53 muestras). El objetivo de este trabajo fue: clasificar las levaduras, su sensibilidad al sistema killer SKI, determinar el tipo killer más frecuente y su relación con la reacción inflamatoria. A su vez, estos resultados se cotejaron con los hallados en otros materiales clínicos. Entre las diversas especies de levaduras aisladas, los mayores porcentajes correspondieron a candida albicans (9,48 por ciento), candida tropicalis (1,72 por ciento), candida parapsilosis, candida glabrata (0, 86 por ciento), y en un 0,29 por ciento a otras especies de candida. El tipo killer más frecuente fue 111 (64 por ciento); siendo tambien el más encontrado en materia fecal (67 por ciento) y en piel y faneras (82 por ciento)


Subject(s)
Humans , Candida/isolation & purification , Leukorrhea/microbiology , Candida/genetics , Candida/pathogenicity , Phenotype , Vaginal Diseases/microbiology , Vaginal Smears/statistics & numerical data
13.
Ginecol. obstet. Méx ; 62(11): 368-73, nov. 1994. tab
Article in Spanish | LILACS | ID: lil-198953

ABSTRACT

Se evaluó la sebsibilidad, especificidad, valor predictivo positivo y negativo y porcentaje de falsas positivas y negativas de tres reactivos de inmunofluorescencia directa para el diagnóstico de infecciones por Chlamydia trachomatis. Se estudiaron 150 muestras de raspados cervicovaginales y 50 muestras de líquido peritoneal de pacientes con enfermedad pélvica inflamatoria. Los reactivos en contra de la proteína principal de membrana externa presentaron mayor sensibilidad pero menor especifidad que el reactivo de inmunofluorescencia contra el lipopolisacárido de Chlamydia trachomatis


Subject(s)
Humans , Female , Chlamydia Infections/diagnosis , Chlamydia trachomatis/pathogenicity , Clinical Laboratory Techniques , Fluorescence , Pelvic Inflammatory Disease/microbiology , Sensitivity and Specificity , Fluorescent Antibody Technique/standards , Vaginal Diseases/microbiology
14.
Ginecol. obstet. Méx ; 62(8): 226-34, ago. 1994. tab, ilus
Article in Spanish | LILACS | ID: lil-198920

ABSTRACT

Se comparó la eficacia y seguridad de clindamicina crema vaginal al 2 por ciento con metronidazol oral en el tratamiento de 184 mujeres con vaginosis bacteriana sintomática en un estudio multicéntrico, aleatorio, doble-ciego, controlado. La duración del tratamiento fue de siete días, utilizando placebo en cápsulas en el grupo clindamicina y placebo crema en el grupo metronidazol. Las pacientes fueron observadas durante las visitas de seguimiento (4-13 y 20-43 días después de completar su terapia). El resultado global del tratamiento, indicó que clindamicina en crama vaginal ofrece una eficacia similar a la demostrada con metronidazol oral. Los porcentajes de curación/mejoría fueron 87 por ciento para el grupo de clindamicina y 79 por ciento para el grupo de metronidazol, sin diferencias significativas (p> 0.22). No se observaron recaídas en el grupo de clindamicina mientras que el grupo de metronidazol, se presentaron en 7 por ciento de los casos. El porcentaje de fracaso fue menor en el grupo de clindamicina (3 por ciento) que en el grupo que recibió metronidazol oral (15 por ciento). Ambos fármacos fueron bien tolerados. Los efectos secundarios más frecuentemente observados fueron irritación vulvovaginal y el desarrollo de vaginitis/cervicitis. El único efecto secundario clasificado como serio fue erupción cutánea generalizada en una paciente que recibió metronidazol. Se concluye que la clindamicina en crema vaginal al 2 por ciento es una alternativa eficaz y segura al metronidazol oral, para el tratamiento de la vaginosis bacteriana; siendo el tratamiento de elección para las mujeres durante el primer trimestre de la gestación


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Vaginal Diseases/microbiology , Vaginitis/therapy
16.
Biomédica (Bogotá) ; 5(3/4): 92-4, jul.-oct. 1985. tab
Article in Spanish | LILACS | ID: lil-81265

ABSTRACT

En 1985 estudiamos, desde el punto de vista del laboratorio, 1178 mujeres adultas para definir la etiologia de su flujo vaginal; se diagnostico vaginosis bacteriana (vaginitis asociada a Gardnerella vaginalis) en 25.3% de los casos, candidiasis en 13.9% y Tricomoniasis en 2.9% en tres pacientes habia levaduras de los generos Geotrichum o Trichosporon cuyo significado en la vagina es desconocido y amerita ser estudiado


Subject(s)
Humans , Female , Vaginal Diseases/microbiology , Bodily Secretions/analysis
17.
Rio de Janeiro; s.n; 1985. 95 p. tab, ilus.
Thesis in Portuguese | LILACS, BDENF, SES-SP | ID: lil-129509

ABSTRACT

O estudo dos corrimentos vaginais agudos e/ou crônicos mostrou presença de bactérias anaeróbias principalmente nos casos crônicos, sendo possível isolar vários gêneros de bactérias anaeróbias de uma mesma paciente. Uma grande populaçäo de microorganismos microaerófilos participaram destas infecçöes vaginais, observadas em 70 pacientes. O antibiograma mostrou-se imprescindível para a indicaçäo do agente antimicrobiano, sendo que várias cepas bacterianas apresentaram resistência a alguns agentes antimicrobianos habituais. Cumpre observar que na nossa pesquisa encontramos algumas culturas puras (grupo B.fragilis) que apresentaram diferentes linhagens (colônias) frente ao antibiograma. Observamos também a presença de bactérias anaeróbias isoladas associadas à presença de Trichomonas.


Subject(s)
Bacteria, Anaerobic , Vaginal Diseases/microbiology , Cross Infection , Bacteria , Bacteria, Anaerobic/isolation & purification , Microbiology , Bacterial Infections
SELECTION OF CITATIONS
SEARCH DETAIL